HIGH

Exactech Recalls Reverse Shoulder Humeral Liners Over Safety Concerns

Exactech recalled 61,334 units of Reverse Shoulder Humeral Liners on August 15, 2025. The liners do not meet specified dimensional standards, posing a risk to patients. Healthcare providers and patients must stop using the devices immediately.

Quick Facts at a Glance

Recall Date
August 15, 2025
Hazard Level
HIGH
Brand
Exactech
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Reverse Shoulder humeral liners have an articular surface position outside of the dimensional specification within the labeling.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Exactech, Inc. or your healthcare provider for instructions. Notification method: E-Mail

Product Details

The recall affects Exactech Reverse Shoulder Humeral Liners, including all serial numbers. The models include REF: 320-38-00, REF: 320-38-03, REF: 320-42-00, and REF: 320-42-03. These products were distributed worldwide, including in the United States.

The Hazard

The recalled humeral liners have an articular surface position outside of the specified dimensional standards. This defect may lead to complications during surgery or recovery.

Reported Incidents

There are no specific incident reports or injuries associated with this recall at this time. The risk level is categorized as high due to potential complications.

What to Do

Patients and healthcare providers should stop using these devices immediately. Contact Exactech, Inc. or your healthcare provider for further instructions and recall details.

Contact Information

For more information, visit Exactech's website or contact them via email. For additional resources, refer to the FDA's recall page.

Key Facts

  • Recall Date: August 15, 2025
  • Quantity Recalled: 61,334 units
  • Risk Level: High
  • Affected Models: All Serial Numbers
  • Distribution: Worldwide

Get Alerts for Health & Personal Care Recalls

Get notified about recalls in categories you care about.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
REF: 320-38-00
REF: 320-38-03
REF: 320-42-00
REF: 320-42-03
Affected States
ALL
Report Date
September 24, 2025
Source Agency
FDA - Medical Devices
Recall Status
ACTIVE

Related Recalls

HIGH

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

SUCRALFATE
CGMP Deviations:
Read more